ArticleBMC pediatrics2025
The role of glucocorticoids in recurrent idiopathic intussusception: a retrospective cohort study.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress on the association between lymphoid hyperplasia and intussusception in the terminal ileum of children.Frontiers in pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to evaluate the efficacy of glucocorticoids in reducing short-term recurrence rate of idiopathic intussusception in pediatric patients.
methodsA retrospective cohort study was conducted on children with recurrent idiopathic intussusception treated at the Emergency Center of Beijing Children's Hospital from January 2015 to January 2024. Patients who experienced three episodes of intussusception within 5 days were included. After successful fluoroscopy-guided air enema (FGAE), some children received glucocorticoids (intervention group), while others did not (control group). Recurrence rates within 14 days were compared between the groups. Lastly, delayed complications and adverse effects related to glucocorticoid use were recorded.
resultsA total of 10,493 FGAE sessions were performed, with 206 patients initially enrolled. Ultimately, 183 patients (124 boys, 59 girls; aged 9 months to 9 years) were included. The recurrence rate was significantly lower in the intervention group compared to the control group (18.6% vs. 46.6%, P = 0.001). Finally, no delayed complications or adverse effects related to glucocorticoid therapy were observed.
conclusionsGlucocorticoids effectively reduced recurrence rate in children with short-term recurrent idiopathic intussusception without eliciting significant adverse effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.